Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
174,282,170
-
Total 13F shares
-
46,131,758
-
Share change
-
+4,393,183
-
Total reported value
-
$675,732,293
-
Price per share
-
$14.65
-
Number of holders
-
77
-
Value change
-
+$67,078,075
-
Number of buys
-
53
-
Number of sells
-
26
Institutional Holders of Prime Medicine, Inc. - COMMON STOCK (PRME) as of Q2 2023
As of 30 Jun 2023,
Prime Medicine, Inc. - COMMON STOCK (PRME) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,131,758 shares.
The largest 10 holders included
Alphabet Inc., FMR LLC, VANGUARD GROUP INC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., BlackRock Inc., ARK Investment Management LLC, PRICE T ROWE ASSOCIATES INC /MD/, FIL Ltd, and MWG Management Ltd..
This page lists
77
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.